Enavate Sciences GP, LLC
SEC insider (Form 3/4/5 filer). CIK 0001953107. 10% Owner at Camp4 Therapeutics Corp (CAMP) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2024. Located in MENLO PARK, CA.
Companies Enavate Sciences GP, LLC has filed insider reports for
- Camp4 Therapeutics Corp (CAMP): 10% Owner
- Zenas BioPharma, Inc. (ZBIO): 10% Owner
Enavate Sciences GP, LLC
CIK: 0001953107
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 15, 2024CAMP
Camp4 Therapeutics Corp
ConversionIndirect2.4M shares- - Oct 15, 2024CAMP
Camp4 Therapeutics Corp
PurchaseIndirect1.4M shares at avg. $11.00$15.0M - Sep 16, 2024ZBIO
Zenas BioPharma, Inc.
ConversionIndirect2.9M shares- - Sep 16, 2024ZBIO
Zenas BioPharma, Inc.
PurchaseIndirect882.4K shares at avg. $17.00$15.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2024 |  CAMP Camp4 Therapeutics Corp | Conversion | 2,422,166 | - | $0 | Indirect |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | Purchase | 1,363,636 | $11.00 | $14,999,996 | Indirect |
| Sep 16, 2024 |  ZBIO Zenas BioPharma, Inc. | Conversion | 2,879,006 | - | $0 | Indirect |
| Sep 16, 2024 | ZBIO Zenas BioPharma, Inc. | Purchase | 882,353 | $17.00 | $15,000,001 | Indirect |
1-4 of 4 transactions